We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (fimasartan)

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: August 27, 2012
Last Update Posted: July 1, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Bucheon St. Mary's Hospital
Konyang University Hospital
Korea University Anam Hospital
National Health Insurance Service Ilsan Hospital
Daegu Fatima Hospital
Dong-A University
Soon Chun Hyang University
Asan Medical Center
Gangnam Severance Hospital
Severance Hospital
Ulsan University Hospital
Kangbuk Samsung Hospital
Sejong General Hospital
Ewha Womans University Mokdong Hospital
Jeju National University Hospital
Hallym University Medical Center
Hanyang University
Information provided by (Responsible Party):
Boryung Pharmaceutical Co., Ltd
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):